Literature DB >> 23063960

Decrease in circulating autotaxin by oral administration of prednisolone.

Hayakazu Sumida1, Kazuhiro Nakamura, Keisuke Yanagida, Ryunosuke Ohkawa, Yoshihide Asano, Takafumi Kadono, Kunihiko Tamaki, Koji Igarashi, Junken Aoki, Shinichi Sato, Satoshi Ishii, Takao Shimizu, Yutaka Yatomi.   

Abstract

BACKGROUND: Autotaxin (ATX), secreted mainly from adipose tissue, functions as a lysophospholipase D (lysoPLD) to hydrolyze lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). ATX-LPA signaling is implicated in a wide range of physiological and pathophysiological processes including immune response.
METHODS: The present study measured serum ATX antigen levels in patients with various autoimmune diseases using a recently developed automated enzyme immunoassay. In addition, serum lysoPLD activity was assessed by measuring choline liberation from the substrate LPC. Moreover, the effect of prednisolone (PSL) on mRNA expression of ATX was evaluated using cultured adipose tissue from mice.
RESULTS: Decreased serum ATX antigen levels were observed after the initiation of treatment with PSL. The decreased levels recovered during tapering of PSL dose in a dose-dependent manner without exacerbation of disease activity. Moreover, decreased ATX mRNA expression in PSL-treated cultured murine adipose tissue suggested that the effect of PSL on serum ATX may have resulted from changes in adipose tissue ATX expression.
CONCLUSIONS: Our results suggest that measurement of serum ATX antigen level may be clinically useful for the assessment of steroid treatment effect and drug compliance with steroids. Furthermore, our findings provide many novel insights into the biosynthesis, physiological functions, pathological roles, and clinical significance of circulating ATX.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063960     DOI: 10.1016/j.cca.2012.10.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Serum autotaxin levels correlate with pruritus in patients with atopic dermatitis.

Authors:  Momoko Nakao; Makoto Sugaya; Hiraku Suga; Makiko Kawaguchi; Sohshi Morimura; Hiromichi Kai; Hanako Ohmatsu; Hideki Fujita; Yoshihide Asano; Yayoi Tada; Takafumi Kadono; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2014-01-17       Impact factor: 8.551

2.  Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.

Authors:  K Schmitz; R Brunkhorst; N de Bruin; C A Mayer; A Häussler; N Ferreiros; S Schiffmann; M J Parnham; S Tunaru; J Chun; S Offermanns; C Foerch; K Scholich; J Vogt; S Wicker; J Lötsch; G Geisslinger; I Tegeder
Journal:  Acta Neuropathol Commun       Date:  2017-06-02       Impact factor: 7.801

3.  Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder.

Authors:  Kei Itagaki; Minoru Takebayashi; Hiromi Abe; Chiyo Shibasaki; Naoto Kajitani; Mami Okada-Tsuchioka; Kotaro Hattori; Sumiko Yoshida; Hiroshi Kunugi; Shigeto Yamawaki
Journal:  Int J Neuropsychopharmacol       Date:  2019-04-01       Impact factor: 5.176

4.  Effect of postoperative corticosteroids on surgical outcome and aqueous autotaxin following combined cataract and microhook ab interno trabeculotomy.

Authors:  Megumi Honjo; Reiko Yamagishi; Nozomi Igarashi; Chui Yong Ku; Makoto Kurano; Yutaka Yatomi; Koji Igarashi; Makoto Aihara
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 5.  Cholestasis-Associated Pruritus and Its Pruritogens.

Authors:  Jacqueline A G M Langedijk; Ulrich H Beuers; Ronald P J Oude Elferink
Journal:  Front Med (Lausanne)       Date:  2021-03-09

6.  Urine autotaxin levels reflect the disease activity of sarcoidosis.

Authors:  Koji Murakami; Tsutomu Tamada; Daisuke Saigusa; Eisaku Miyauchi; Masayuki Nara; Masakazu Ichinose; Makoto Kurano; Yutaka Yatomi; Hisatoshi Sugiura
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.379

7.  Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease.

Authors:  Takuma Isshiki; Hiroshige Shimizu; Susumu Sakamoto; Akira Yamasaki; Shion Miyoshi; Yasuhiko Nakamura; Sakae Homma; Kazuma Kishi
Journal:  ERJ Open Res       Date:  2022-04-11

8.  Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C.

Authors:  Wataru Ando; Hiroaki Yokomori; Fumihiko Kaneko; Mana Kaneko; Koji Igarashi; Hidekazu Suzuki
Journal:  Hepatol Commun       Date:  2018-08-23

9.  Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy.

Authors:  Jörn Lötsch; Susanne Schiffmann; Katja Schmitz; Robert Brunkhorst; Florian Lerch; Nerea Ferreiros; Sabine Wicker; Irmgard Tegeder; Gerd Geisslinger; Alfred Ultsch
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

10.  Serum autotaxin as a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.

Authors:  Takashi Araki; Takahiro Okumura; Hiroaki Hiraiwa; Takashi Mizutani; Yuki Kimura; Shingo Kazama; Naoki Shibata; Hideo Oishi; Tasuku Kuwayama; Toru Kondo; Ryota Morimoto; Mikito Takefuji; Toyoaki Murohara
Journal:  ESC Heart Fail       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.